閉塞性肥大型心筋症:病態生理と診断
Miguel Marques Antunes1,2,3, José Miguel Viegas1, Vera Vaz Ferreira1
1Serviço de Cardiologia, Hospital de Santa Marta, Centro Clínico Académico de Lisboa (CCAL), Lisbon, Portugal.
Indian journal of thoracic and cardiovascular surgery
|January 30, 2026
まとめ
肥大型心筋症(HCM)は、左室(LV)肥大と流出路閉塞を引き起こす遺伝性心疾患です。個別化された治療戦略には、高度な画像診断を用いた包括的な評価が不可欠です。
科学分野:
- 心臓学
- 遺伝学
- 医用画像
背景:
- 肥大型心筋症(HCM)は、左室(LV)肥大を特徴とする遺伝性心疾患です。
- 閉塞性HCMは、中隔肥大や僧帽弁の問題などの構造的異常を伴います。
- 病態生理には、過度の収縮、心筋細胞の配列異常、線維化、冠状動脈微小血管機能不全が含まれます。
研究 の 目的:
- 閉塞性HCMにおける遺伝的、構造的、機能的要素の複雑な相互作用をレビューすること。
- 効果的な治療決定のために包括的な評価の重要性を強調すること。
主な方法:
- 診断は、臨床症状、身体診察、ECG、遺伝子検査、および高度な画像診断を統合します。
- 経胸壁心エコー検査は、肥大、LVOT勾配、および弁機能の評価における主要なツールです。
- 心臓MRIは、解剖学的詳細、LV質量定量化、および線維化検出のために心エコー検査を補完します。
主要な成果:
- HCMの診断は、複数の臨床および画像検査法を統合することに依存しています。
- 心エコー検査と心臓MRIは、HCMの詳細な評価に不可欠です。
- 高度な画像診断は、特定のパターンや線維化の特定を支援し、治療を導きます。
結論:
- 閉塞性HCMの多面的な性質を理解することが鍵となります。
- 包括的な診断評価は、患者管理の個別化に不可欠です。
- 個別化された治療戦略は、閉塞性HCMの転帰を改善します。
関連する概念動画
Cardiomyopathy III: Hypertrophic Cardiomyopathy
486
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
486
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.5K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.5K
Cardiomyopathy II: Dilated Cardiomyopathy
563
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
563
Cardiomyopathy IV: Restrictive Cardiomyopathy
532
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
532
Cardiomyopathy V: Interprofessional Care
442
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
442
Cardiomyopathy I: Introduction and Classification
603
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
603


